Alginate biomaterial for the treatment of myocardial infarction: Progress, translational strategies, and clinical outlook: From ocean algae to patient bedside.

Alginate biomaterial is widely utilized for tissue engineering and regeneration due to its biocompatibility, non-thrombogenic nature, mild and physical gelation process, and the resemblance of its hydrogel matrix texture and stiffness to that of the extracellular matrix. In this review, we describe the versatile biomedical applications of alginate, from its use as a supporting cardiac implant in patients after acute myocardial infarction (MI) to its employment as a vehicle for stem cell delivery and for the controlled delivery and presentation of multiple combinations of bioactive molecules and regenerative factors into the heart. Preclinical and first-in-man clinical trials are described in details, showing the therapeutic potential of injectable acellular alginate implants to inhibit the damaging processes after MI, leading to myocardial repair and tissue reconstruction.

[1]  M. Tendera,et al.  Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies? , 2012, Leukemia.

[2]  M. Harmsen,et al.  Signaling factors in stem cell-mediated repair of infarcted myocardium. , 2005, Journal of molecular and cellular cardiology.

[3]  Q. Li,et al.  Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. , 1997, The Journal of clinical investigation.

[4]  F. Rosso,et al.  From Cell–ECM interactions to tissue engineering , 2004, Journal of cellular physiology.

[5]  J. Leor,et al.  Intracoronary Delivery of Injectable Bioabsorbable Scaffold (IK-5001) to Treat Left Ventricular Remodeling After ST-Elevation Myocardial Infarction: A First-in-Man Study , 2014, Circulation. Cardiovascular interventions.

[6]  D. Mooney,et al.  Controlling rigidity and degradation of alginate hydrogels via molecular weight distribution. , 2004, Biomacromolecules.

[7]  P. Menasché.  Stem cells in the management of advanced heart failure , 2015, Current opinion in cardiology.

[8]  R. Loeser.  Integrins and cell signaling in chondrocytes. , 2002, Biorheology.

[9]  Smadar Cohen,et al.  Effect of Injectable Alginate Implant on Cardiac Remodeling and Function After Recent and Old Infarcts in Rat , 2008, Circulation.

[10]  Smadar Cohen,et al.  The influence of the sequential delivery of angiogenic factors from affinity-binding alginate scaffolds on vascularization. , 2009, Biomaterials.

[11]  Smadar Cohen,et al.  Tailoring the pore architecture in 3-D alginate scaffolds by controlling the freezing regime during fabrication. , 2002, Biomaterials.

[12]  Robert Bauernschmitt,et al.  Polymer-Based Restoration of Left Ventricular Mechanics , 2013, Cell transplantation.

[13]  Tal Dvir,et al.  Nanowired three dimensional cardiac patches , 2011, Nature nanotechnology.

[14]  Artur Lichtenberg,et al.  Myocardial tissue engineering: the extracellular matrix. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[15]  David J Mooney,et al.  Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction. , 2007, Cardiovascular research.

[16]  Jonathan D. Suever,et al.  Cellular Encapsulation Enhances Cardiac Repair , 2013, Journal of the American Heart Association.

[17]  N. Kashihara,et al.  Apoptosis and extracellular matrix-cell interactions in kidney disease. , 2000, Kidney international. Supplement.

[18]  Karim Senni,et al.  Marine Polysaccharides: A Source of Bioactive Molecules for Cell Therapy and Tissue Engineering , 2011, Marine drugs.

[19]  Zachary Shriver,et al.  Emerging views of heparan sulfate glycosaminoglycan structure/activity relationships modulating dynamic biological functions. , 2002, Trends in cardiovascular medicine.

[20]  T. Lüscher,et al.  Cell-based cardiovascular repair and regeneration in acute myocardial infarction and chronic ischemic cardiomyopathy-current status and future developments. , 2011, The International journal of developmental biology.

[21]  P. Jones,et al.  The tenascin family of ECM glycoproteins: Structure, function, and regulation during embryonic development and tissue remodeling , 2000, Developmental dynamics : an official publication of the American Association of Anatomists.

[22]  Smadar Cohen,et al.  The effect of sulfation of alginate hydrogels on the specific binding and controlled release of heparin-binding proteins. , 2008, Biomaterials.

[23]  C. Stewart,et al.  Apoptosis and the cardiac action of insulin-like growth factor I. , 2007, Pharmacology & therapeutics.

[24]  Thomas Eschenhagen,et al.  Cardiac tissue engineering: state of the art. , 2014, Circulation research.

[25]  G. Camussi,et al.  Role of stem-cell-derived microvesicles in the paracrine action of stem cells. , 2013, Biochemical Society transactions.

[26]  Smadar Cohen,et al.  Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine. , 2009, Journal of the American College of Cardiology.

[27]  Smadar Cohen,et al.  Cardiac Tissue Engineering , 2012 .

[28]  K. Matsumoto,et al.  Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. , 2000, The Journal of clinical investigation.

[29]  Gordana Vunjak-Novakovic,et al.  Bioengineering heart muscle: a paradigm for regenerative medicine. , 2011, Annual review of biomedical engineering.

[30]  D. Yellon,et al.  Cardioprotective growth factors. , 2009, Cardiovascular research.

[31]  Smadar Cohen,et al.  Optimization of cardiac cell seeding and distribution in 3D porous alginate scaffolds. , 2002, Biotechnology and bioengineering.

[32]  C. Walsh,et al.  Comparison of biomaterial delivery vehicles for improving acute retention of stem cells in the infarcted heart. , 2014, Biomaterials.

[33]  L. Shapiro,et al.  Novel alginate sponges for cell culture and transplantation. , 1997, Biomaterials.

[34]  Joseph H. Gorman,et al.  Acellular Biomaterials: An Evolving Alternative to Cell-Based Therapies , 2013, Science Translational Medicine.

[35]  David J Mooney,et al.  Alginate hydrogels as biomaterials. , 2006, Macromolecular bioscience.

[36]  N. Frangogiannis,et al.  The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. , 2010, Journal of molecular and cellular cardiology.

[37]  Randall J Lee,et al.  Biomaterials for the treatment of myocardial infarction. , 2006, Journal of the American College of Cardiology.

[38]  M. Gnecchi,et al.  Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. , 2011, Journal of molecular and cellular cardiology.

[39]  E. Alsberg,et al.  Chapter 9:Alginates as biomaterials in tissue engineering , 2011 .

[40]  Samuel T Wall,et al.  Theoretical Impact of the Injection of Material Into the Myocardium: A Finite Element Model Simulation , 2006, Circulation.

[41]  David J Mooney,et al.  Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution. , 2005, Biomaterials.

[42]  Ruth Duncan,et al.  Radioiodination of Alginate via Covalently-Bound Tyrosinamide Allows Monitoring of its Fate In Vivo , 1995 .

[43]  K. Webster.  Programmed death as a therapeutic target to reduce myocardial infarction. , 2007, Trends in pharmacological sciences.

[44]  K. Rayner,et al.  Timing underpins the benefits associated with injectable collagen biomaterial therapy for the treatment of myocardial infarction. , 2015, Biomaterials.

[45]  Tal Dvir,et al.  The effect of immobilized RGD peptide in alginate scaffolds on cardiac tissue engineering. , 2011, Acta biomaterialia.

[46]  Smadar Cohen,et al.  Integration of multiple cell-matrix interactions into alginate scaffolds for promoting cardiac tissue regeneration. , 2011, Biomaterials.

[47]  Smadar Cohen,et al.  Cardiac tissue engineering in magnetically actuated scaffolds , 2014, Nanotechnology.

[48]  Eben Alsberg,et al.  Degradation of Partially Oxidized Alginate and Its Potential Application for Tissue Engineering , 2001, Biotechnology progress.

[49]  Randall J. Lee,et al.  Augmentation of left ventricular wall thickness with alginate hydrogel implants improves left ventricular function and prevents progressive remodeling in dogs with chronic heart failure. , 2013, JACC. Heart failure.

[50]  D. Mooney,et al.  Alginate: properties and biomedical applications. , 2012, Progress in polymer science.

[51]  J. Leor,et al.  The effects of peptide-based modification of alginate on left ventricular remodeling and function after myocardial infarction. , 2009, Biomaterials.

[52]  B. Jugdutt,et al.  Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? , 2003, Circulation.

[53]  K. Christman,et al.  Biomaterials for the treatment of myocardial infarction: a 5-year update. , 2011, Journal of the American College of Cardiology.

[54]  D. Mooney,et al.  Growth factor delivery-based tissue engineering: general approaches and a review of recent developments , 2011, Journal of The Royal Society Interface.

[55]  A. Cardin,et al.  Molecular Modeling of Protein‐Glycosaminoglycan Interactions , 1989, Arteriosclerosis.

[56]  Jennifer M. Singelyn,et al.  Injectable Materials for the Treatment of Myocardial Infarction and Heart Failure: The Promise of Decellularized Matrices , 2010, Journal of cardiovascular translational research.

[57]  B. Gumbiner,et al.  Cell Adhesion: The Molecular Basis of Tissue Architecture and Morphogenesis , 1996, Cell.

[58]  J. Leor,et al.  Bioengineered Cardiac Grafts: A New Approach to Repair the Infarcted Myocardium? , 2000, Circulation.

[59]  N. Boudreau,et al.  Extracellular matrix and integrin signalling: the shape of things to come. , 1999, The Biochemical journal.

[60]  E. Brey,et al.  Alginate-based strategies for therapeutic vascularization. , 2013, Therapeutic delivery.

[61]  Tal Dvir,et al.  Prevascularization of cardiac patch on the omentum improves its therapeutic outcome , 2009, Proceedings of the National Academy of Sciences.

[62]  H. Matsuda,et al.  Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts. , 2005, American journal of physiology. Heart and circulatory physiology.

[63]  Eben Alsberg,et al.  Controlling Degradation of Hydrogels via the Size of Crosslinked Junctions , 2004, Advanced materials.

[64]  Richard T. Lee,et al.  Biomaterials to enhance stem cell function in the heart. , 2011, Circulation research.

[65]  Randall J. Lee,et al.  The effect of injected RGD modified alginate on angiogenesis and left ventricular function in a chronic rat infarct model. , 2009, Biomaterials.

[66]  J. Hare,et al.  The Advancing Field of Cell‐Based Therapy: Insights and Lessons From Clinical Trials , 2013, Journal of the American Heart Association.

[67]  H. Ly,et al.  The Paracrine Effect: Pivotal Mechanism in Cell-Based Cardiac Repair , 2010, Journal of cardiovascular translational research.

[68]  Z. Werb,et al.  ECM signalling: orchestrating cell behaviour and misbehaviour. , 1998, Trends in cell biology.

[69]  Antonios G Mikos,et al.  Biomimetic materials for tissue engineering. , 2003, Biomaterials.

[70]  J. Leor,et al.  The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction. , 2011, Biomaterials.

[71]  F. Crea,et al.  Insulin-Like Growth Factor-1 as a Vascular Protective Factor , 2004, Circulation.

[72]  Smadar Cohen,et al.  The effects of controlled HGF delivery from an affinity-binding alginate biomaterial on angiogenesis and blood perfusion in a hindlimb ischemia model. , 2010, Biomaterials.

[73]  F. Lallemand,et al.  Arteriogenic Therapy by Intramyocardial Sustained Delivery of a Novel Growth Factor Combination Prevents Chronic Heart Failure , 2011, Circulation.

[74]  S. Silver,et al.  Heart Failure , 1937, The New England journal of medicine.

[75]  Paola Laurienzo,et al.  Marine Polysaccharides in Pharmaceutical Applications: An Overview , 2010, Marine drugs.

[76]  Y. Taniyama,et al.  Angiogenic Property of Hepatocyte Growth Factor Is Dependent on Upregulation of Essential Transcription Factor for Angiogenesis, ets-1 , 2003, Circulation.

[77]  Joseph H. Gorman,et al.  Algisyl-LVR™ with coronary artery bypass grafting reduces left ventricular wall stress and improves function in the failing human heart. , 2013, International journal of cardiology.

[78]  S. Fisher,et al.  Meta-analysis of cell therapy trials for patients with heart failure. , 2015, Circulation research.

[79]  J. Leor,et al.  Myocardial repair: from salvage to tissue reconstruction , 2008, Expert review of cardiovascular therapy.

[80]  M. Gnecchi,et al.  Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy , 2008, Circulation research.

[81]  G. Ertl,et al.  Post-infarct remodelling: contribution of wound healing and inflammation , 2008, Cardiovascular research.

[82]  M. Ashraf,et al.  Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis. , 2004, Journal of molecular and cellular cardiology.

[83]  T. Oda,et al.  Biological activities of alginate. , 2014, Advances in food and nutrition research.